ARIS vs. RIGL
ARIS (Aris Water Solutions, Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. ARIS operates in Utilities - Regulated Water (Utilities), while RIGL operates in Biotechnology (Healthcare). Over the past 3 years, ARIS returned 84.20%/yr vs 23.16%/yr for RIGL. At a 0.12 correlation, their price movements are largely independent.
Performance
ARIS vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARIS achieves a -4.50% return, which is significantly higher than RIGL's -29.77% return.
ARIS
- 1D
- 1.77%
- 1M
- -21.32%
- YTD
- -4.50%
- 6M
- 11.51%
- 1Y
- 146.03%
- 3Y*
- 84.20%
- 5Y*
- —
- 10Y*
- —
RIGL
- 1D
- 0.50%
- 1M
- 15.51%
- YTD
- -29.77%
- 6M
- -30.69%
- 1Y
- 39.97%
- 3Y*
- 23.16%
- 5Y*
- -5.96%
- 10Y*
- 2.33%
ARIS vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | -4.50% | 363.71% | 6.54% | 31.93% | -39.60% | 0.22% |
RIGL Rigel Pharmaceuticals, Inc. | -29.77% | 154.64% | 16.00% | -3.33% | -43.40% | -18.21% |
Correlation
The correlation between ARIS and RIGL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2021 | 0.12 |
Fundamentals
ARIS:
$3.24B
RIGL:
$592.15M
ARIS:
$0.87
RIGL:
$19.21
ARIS:
17.74
RIGL:
1.57
ARIS:
0.35
RIGL:
0.00
ARIS:
2.70
RIGL:
1.90
ARIS:
2.06
RIGL:
1.48
ARIS:
$1.14B
RIGL:
$299.77M
ARIS:
$612.94M
RIGL:
$279.95M
ARIS:
$432.53M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARIS vs. RIGL — Risk / Return Rank
ARIS
RIGL
ARIS vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aris Water Solutions, Inc. (ARIS) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARIS | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.57 | ||
| Sortino ratioReturn per unit of downside risk | +1.56 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.17 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 6.09 | 0.80 | +5.28 |
| Martin ratioReturn relative to average drawdown | 20.00 | 1.41 | +18.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARIS | RIGL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.14 | 0.58 | +2.57 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.07 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.03 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.65 | -0.13 | +0.78 |
Drawdowns
ARIS vs. RIGL - Drawdown Comparison
The maximum ARIS drawdown since its inception was -57.98%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for ARIS and RIGL.
Loading charts...
Drawdown Indicators
| ARIS | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.98% | -99.37% | +41.39% |
Max Drawdown (1Y)Largest decline over 1 year | -29.65% | -50.08% | +20.43% |
Max Drawdown (3Y)Largest decline over 3 years | -34.46% | -57.75% | +23.29% |
Max Drawdown (5Y)Largest decline over 5 years | — | -85.24% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.40% | — |
Current DrawdownCurrent decline from peak | -28.41% | -97.18% | +68.77% |
Average DrawdownAverage peak-to-trough decline | -22.66% | -90.92% | +68.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 28.34% | -19.81% |
Volatility
ARIS vs. RIGL - Volatility Comparison
Aris Water Solutions, Inc. (ARIS) has a higher volatility of 19.23% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 18.26%. This indicates that ARIS's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARIS | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.23% | 18.26% | +0.97% |
Volatility (6M)Calculated over the trailing 6-month period | 46.18% | 38.39% | +7.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.59% | 69.94% | -12.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.00% | 85.50% | -32.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.00% | 82.83% | -29.83% |
Dividends
ARIS vs. RIGL - Dividend Comparison
Neither ARIS nor RIGL has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 3.84% | 0.85% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ARIS vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Aris Water Solutions, Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ARIS vs. RIGL - Profitability Comparison
ARIS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aris Water Solutions, Inc. reported a gross profit of 217.03M and revenue of 372.48M. Therefore, the gross margin over that period was 58.3%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
ARIS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aris Water Solutions, Inc. reported an operating income of 179.05M and revenue of 372.48M, resulting in an operating margin of 48.1%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
ARIS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aris Water Solutions, Inc. reported a net income of 97.61M and revenue of 372.48M, resulting in a net margin of 26.2%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
ARIS and RIGL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARIS has higher volatility (19.23%) compared to RIGL (18.26%). In terms of maximum drawdown, ARIS dropped -57.98% vs RIGL's -99.37%.
ARIS currently has the higher Sharpe Ratio (3.14 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARIS and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer